Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Oct 14 - Oct 19
Diabetes Obes Metab 22(6):10011005
At present, long-acting GLP-1 agonist holds the maximum share of the GLP-1 market and this trend is likely to remain the same in the forthcoming years
Large-scale outcome trials involve substantial investment, lengthy follow-up periods, and extensive safety evaluations before regulatory approval
December 22, 2023: A plaintiff in Louisiana filed a lawsuit against pharmaceutical giants Novo Nordisk and Eli Lilly & Co
doi: 10.1111/j.1476-5381.2009.00486.x
US$ 21.50
US$ 27.02
US$ 27.46
US$ 21.27
US$ 26.73
US$ 17475.00
Sold : Login>>
